Intimation to shareholders about deduction of tax at source (TDS) on Final Dividend for FY 2026-26, if approved by the members at the ensuing AGM

August 01, 2026 BSE Limited The National Stock Exchange of India Limited Floor 25, P. J. Towers Exchange Plaza Dalal Street, Bandra Kurla Complex, Bandra (E) Mumbai - 400 001 Mumbai - 400 051 Scrip Code: 530019 Symbol: JUBLPHARMA Sub.: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 Ref.: E-mail to shareholders intimating about deduction of tax at source (TDS) on Final Dividend for FY 2025-26 Dear Madam/Sirs, Please find attached herewith a communication sent to shareholders on August 1, 2026, relating to Deduction of Tax at Source on the Final Dividend for FY 2025-26, if approved by the Members of the Company at the ensuing Annual General Meeting and the procedures to be followed by the Members for submission of relevant forms, documents, etc. in this regard. The above details will also be available on the website of the Company at www.jubilantpharmova.com. We request you to take the same on record. Thanking you, Yours faithfully, For Jubilant Pharmova Limited Naresh Kapoor Company Secretary Encl.: As above JUBILANT PHARMOVA LIMITED (CIN: L24116UP1978PLC004624) Regd. Office: Bhartiagram, Gajraula, District Amroha - 244223, Uttar Pradesh, India Tele: +91-5924-267437 Email: investors@jubl.com; website: www.jubilantpharmova.com Dear Shareholder, We hope that you and your family are doing well and are safe and healthy. We are pleased to inform that the Board of Directors of Jubilant Pharmova Limited (‘the Company’) at their meeting held on Friday, May 22, 2026 have recommended payment of final dividend of ` 5 per equity share of face value of Re.1/- (Rupee One) each for the Financial year ended March 31, 2026, subject to approval of the shareholders at the ensuing Annual General Meeting (AGM) of the Company. The Final dividend will be paid to those shareholders who hold equity shares of the Company as on the closure of record date i.e. Friday, July 24, 2026. Pursuant to the provisions of the Income-tax Act, 2025 (‘the Act’), the Company will be required to withhold taxes at the prescribed rates on the dividend paid to its shareholders. No tax will be deducted on payment of dividend to the resident individual shareholder if the total dividend, paid during Financial year (‘FY’) 2026-27, does not exceed INR 10,000/- The withholding tax rate would vary depending on the residential status, category of the shareholder and is subject to provision of requisite declarations / documents to the Company. 1. RESIDENT SHAREHOLDERS: A.1 Tax deductible at source for Resident Shareholders: Sr. Particular Withholding Declaration/ documents required No. tax rate 1 Valid PAN updated in the 10% No document required. Company’s Register of In case of individual Member, if dividend does not exceed Members ` 10,000, no TDS / withholding tax will be deducted. Also, please refer note (v) below. 2 No PAN / Valid PAN not 20% TDS will be deducted at 20% as provided under Section 397(2) updated in the Company’s of the Income Tax Act, 2025, regardless of dividend amount, Register of Members/ PAN if PAN of the member other than individual is not registered is not linked with AADHAR with the Company / Alankit Assignments Limited / Depository in case of an individual Participant. In case of individual member, if PAN is not registered with the Company / Alankit Assignments Limited / Depository Participant & cumulative dividend payment to an individual member is more than ` 10,000, TDS / Withholding tax will be deducted at 20% under Section 397(2) of the Income-Tax Act, 2025. All the members are requested to update, on or before August 14, 2026, their PAN with their Depository Participant (if shares are held in dematerialised mode) and Company / Alankit Assignments Limited (if shares are held in physical mode). Please quote all the folio numbers under which you hold your shares while updating the records. JUBILANT PHARMOVA LIMITED Sr. Particular Withholding Declaration/ documents required No. tax rate 3 Availability of lower/nil tax Rate specified Lower tax deduction certificate obtained from Income Tax deduction certificate issued in the certificate Authority to be submitted on or before August 14, 2026 by Income-Tax Department u/s 395(1) of the Income- Tax Act, 2025 4 Benefits under Income Tax Rates based on If the member e.g. clearing member / intermediaries / stock Rule 203 applicability of brokers are not the beneficial shareholders of the shares and the Income-Tax if the declaration under Income Tax Rule 203(2) is provided Act, 2025 to the regarding the beneficial owner, the TDS / Withholding tax will be beneficial owner deducted at the rates applicable to the beneficial shareholders. A.2 Nil Tax Deductible at Source on dividend payment to Resident Shareholders if the Shareholders submit documents mentioned in table below with the Alankit Assignments Limited / Depository Participant on or before August 14, 2026. Sr. Particular Withholding Declaration / documents required No. tax rate 1 Submission of form 121 with valid & NIL Declaration in Form No. 121 fulfilling certain conditions. operative PAN. 2 Member to whom section 393(1) NIL Valid documentary evidence for exemption u/s 393(4) [Table: Sl. No. 7] of the Income-Tax [Table Sl. No 10] of the Income-Tax Act, 2025. Act, 2025 does not apply as per section 393(4) [Table: Sl. No. 10] such as LIC, GIC. etc. 3 Member covered u/s 393(5) of the NIL Valid documentary evidence for coverage u/s 393(5) of Income-Tax Act, 2025 such as the Income-Tax Act, 2025. Government, RBI, Corporations established by Central Act & mutual funds 4 Category I and II Alternate NIL SEBI registration certificate to claim benefit under Investment Fund section 400(1) of the Income-Tax Act, 2025. 5 ƒ Recognised provident funds NIL Valid documentary evidence as per Circular No. 18/2017 issued by Central Board of Direct Taxes (CBDT). ƒ Approved superannuation fund ƒ Approved gratuity fund 6 National Pension Scheme NIL No TDS as per section 393(9) of the Income-Tax Act, 2025. Valid documentary evidence (e.g., relevant copy of registration, notification, order, etc.) to be provided. 7 Any resident member exempted NIL Valid documentary evidence substantiating exemption from TDS deduction as per the from deduction of TDS. provisions of the Income-Tax Act, 2025 or by any other law or notification 2. NON-RESIDENT SHAREHOLDERS: The table below shows the withholding tax on dividend payment to non-resident shareholders. Shareholders are requested to submit the document(s) as mentioned in column no. (4) of the below table on or before August 14, 2026, to the Company / Alankit Assignments Limited to avail the beneficial rates, wherever applicable. Sr. Category Withholding tax rate Declaration / documents required 1 Foreign Institutional Investors 20% (plus applicable FPI registration certificate in case of FIIs / FPIs. To avail surcharge and cess) beneficial rate of tax treaty following tax documents would (FIIs) / Foreign Portfolio or tax treaty rate, be required: Investors (FPIs) / Other Non- whichever is beneficial Resident members 1. Tax Residency certificate issued by revenue authority of country of residence of member for the year in which dividend is received. 2. PAN or declaration as per Rule 217 of the Income-Tax Rules, 2026 in a specified format. 3. E-filed Form 41 4. Self-declaration for non-existence of permanent establishment/ fixed base in India. (Note: Application of beneficial Tax Treaty Rate shall depend upon the completeness of the documents submitted by the Non-Resident member and review to the satisfaction of the Company). 2 Indian Branch of a Foreign NIL Lower tax deduction certificate u/s 395(1) of the Income- Bank Tax Act, 2025 obtained from Income Tax Authority. Self-declaration confirming that the income is received on its own account and not on behalf of the Foreign Bank and the same will be included in taxable income of the branch in India. In case above documents are not made available [Showing first 8,000 characters — download PDF for full document]